Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia.
Journal Information
Full Title: Pharmaceuticals (Basel)
Abbreviation: Pharmaceuticals (Basel)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest The authors declare no conflicts of interest."
"This research was funded by Instituto Nacional de Psiquiatría Ramón de la Fuente Muñíz (Number: SC-1524-14), Secteraría de Ciencia, Tecnología e Innovación (Number: 0048/2014), and Consejo Nacional de Ciencia y Tecnología, Fondo Sectorial de Ciencia en Salud y Seguridad Social (Number: SALUD-2017-1-289800). All authors declare that the funding sources had no impact on the study design, in the collection, analysis and interpretation of data, neither in the writing of the report, nor in the decision to submit the paper for publication."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025